Core Viewpoint - Henan Lingrui Pharmaceutical Co., Ltd. has established itself as a household name in the pain relief patch market through innovative production techniques and product development. Group 1: Production Innovations - The company utilizes smart manufacturing technologies, including self-developed digital extraction equipment, to enhance the efficiency, environmental sustainability, and energy conservation of traditional Chinese medicine extraction [2][3]. - A centralized control center monitors over 300 production data points in real-time, ensuring quality stability across different batches of herbal extracts [3]. - The integration of an intelligent logistics and warehousing system has created a "digital highway" from production to shipping, incorporating advanced technologies such as AGV systems and drug traceability [3]. Group 2: Product Development - Lingrui Pharmaceutical has expanded its product line beyond traditional patches, introducing innovative products like the indomethacin patch, which employs advanced laser micropore technology for enhanced functionality [4]. - The company is actively developing new products, including a novel nasal spray for treating cold symptoms, which is expected to broaden its therapeutic applications and clinical value [5]. - The annual sales of the "Two Tigers" patch series have exceeded 1 billion patches, covering various medical fields such as orthopedics, neurology, respiratory medicine, anesthesiology, dermatology, and pediatrics [5]. Group 3: Investment in R&D - Lingrui Pharmaceutical commits 3% to 5% of its annual revenue to research and development, establishing high-level platforms such as a national enterprise technology center and a postdoctoral research workstation [5]. - The company's approach demonstrates that the heritage of traditional brands can serve as a foundation for innovation, enabling them to navigate market cycles and achieve high-quality growth [5].

Core Insights - The company, Lingrui Pharmaceutical, has established itself as a household name in the production of medicated plasters, leveraging advanced technology and innovation to enhance product quality and production efficiency [1][2][3] Group 1: Production and Technology - Lingrui Pharmaceutical has implemented smart manufacturing systems, including a digital extraction process that ensures the quality stability of traditional Chinese medicine extracts [1] - The company has developed an integrated ERP data platform that connects sales, production, and inventory data, allowing for real-time intelligent production scheduling and energy-efficient operations [2] - The production facility is capable of producing 10,000 medicated plasters per minute, showcasing the efficiency of its smart manufacturing processes [1] Group 2: Product Development and Market Position - The company has expanded its product line through continuous research and development, with its "Two Tigers" medicated plaster series achieving annual sales exceeding 1 billion plasters [3] - Lingrui Pharmaceutical is set to launch a new innovative drug, a nasal spray for treating cold symptoms, which will broaden its therapeutic offerings and enhance clinical value [3] - The company invests 3% to 5% of its annual revenue into research and development, establishing high-level platforms such as a national enterprise technology center and a postdoctoral research workstation [3]